The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum
- PMID: 36408515
- PMCID: PMC9669339
- DOI: 10.3389/fneur.2022.961842
The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum
Abstract
Brain iron accumulation, which is indicated in the cerebrospinal fluid (CSF) ferritin, is associated with the development of Alzheimer's Disease (AD). Studies have indicated that iron deposition might participate in Alzheimer's pathology through the induction of microglial activation. A soluble triggering receptor expressed on myeloid cells 2 (sTrem2) in CSF is increasingly recognized as a reliable indicator for microglia activity in the brain and participates in the development of neuroinflammation. However, the association between CSF ferritin and sTrem2 under the AD continuum has not been well-established. We enrolled individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Participants were classified into healthy controls (HC, n = 46) and AD continuum (n = 105) in the combined strata of Amyloid/Tau/Neurodegeneration (ATN) mode and Clinical Dementia Rating (CDR) criteria. The associations between CSF ferritin (indicating iron burden) and sTrem2, as well as AD pathology, which is reflected by Aβ42, t-tau, and p-tau in CSF, were explored. CSF ferritin was significantly associated with sTrem2 among all participants (β = 0.517, P < 0.001, FDR < 0.001), HC (β = 0.749, P = 0.006, FDR = 0.010), and AD continuum (β = 0.488, P < 0.001, FDR < 0.001), respectively. However, ferritin predicted the accelerated sTrem2 level in those with high ferritin (β = 0.549, P = 0.036, FDR = 0.045). In conclusion, CSF ferritin serves as a potential biomarker of Trem2-indicated microglia function.
Keywords: Alzheimer's Disease; ferritin; iron; neuroinflammation; sTrem2.
Copyright © 2022 Shi, Zhong, Zhou, Zhou, Hu, Ning and Alzheimer's Disease Neuroimaging Initiative.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.Mol Neurodegener. 2019 Jan 10;14(1):1. doi: 10.1186/s13024-018-0301-5. Mol Neurodegener. 2019. PMID: 30630532 Free PMC article.
-
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.Sci Rep. 2024 Jul 3;14(1):15318. doi: 10.1038/s41598-024-66211-w. Sci Rep. 2024. PMID: 38961148 Free PMC article.
-
Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.J Alzheimers Dis. 2022;90(3):1123-1138. doi: 10.3233/JAD-220598. J Alzheimers Dis. 2022. PMID: 36213998
-
TREM2 ectodomain and its soluble form in Alzheimer's disease.J Neuroinflammation. 2020 Jul 7;17(1):204. doi: 10.1186/s12974-020-01878-2. J Neuroinflammation. 2020. PMID: 32635934 Free PMC article. Review.
-
Does Soluble TREM2 Protect Against Alzheimer's Disease?Front Aging Neurosci. 2022 Jan 28;13:834697. doi: 10.3389/fnagi.2021.834697. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35153729 Free PMC article. Review.
Cited by
-
sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden.Front Neurol. 2024 Dec 10;15:1515252. doi: 10.3389/fneur.2024.1515252. eCollection 2024. Front Neurol. 2024. PMID: 39722698 Free PMC article.
-
Potential significance of high-mobility group protein box 1 in cerebrospinal fluid.Heliyon. 2023 Nov 3;9(11):e21926. doi: 10.1016/j.heliyon.2023.e21926. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027583 Free PMC article. Review.
-
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12. Alzheimers Dement. 2024. PMID: 37698424 Free PMC article. Review.
-
New Perspectives on Circulating Ferritin: Its Role in Health and Disease.Molecules. 2023 Nov 22;28(23):7707. doi: 10.3390/molecules28237707. Molecules. 2023. PMID: 38067440 Free PMC article. Review.
-
Decoding sTREM2: its impact on Alzheimer's disease - a comprehensive review of mechanisms and implications.Front Aging Neurosci. 2024 Jun 7;16:1420731. doi: 10.3389/fnagi.2024.1420731. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38912524 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources